Two voluntary marijuana product recalls occur in California, financial hurdles stymie diversity in Massachusetts’ recreational MJ industry, and Detroit caps the number of medical cannabis licenses at 75.
Here’s a closer look at some notable developments in the cannabis industry over the past week.
It’s been a month since mandated lab testing for all cannabis products began in California. And it’s been rough sailing for many companies.
Not only have there been two voluntary product recalls tied to testing issues, but roughly one in five samples are failing at labs across the state for various reasons, according to data from the state Bureau of Cannabis Control.
What does this mean for California operators in the near term?
More recalls are likely, observed Donald Land, a professor of chemistry at the University of California, Davis, and chief